Lanreotide as Treatment of Polycystic Livers

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2007
To assess the efficacy of lanreotide in controling total liver volume in patients with polycystic livers this study will be performed. A minimum of 38 patients will be recruited and randomized (1:1) to receive either verum or placebo. Lanreotide is already used in other disease states and found to be safe and non-toxic.
Epistemonikos ID: 14646460d1a3664ad8e84c121cb877ecc3d3d726
First added on: May 04, 2024